Effects of the T-type Ca2+ channel blocker mibefradil on repolarization of guinea pig, rabbit, dog, monkey, and human cardiac tissue

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 2, 2000, Pages 561-575

  Bénardeau, Agnès ^a   Weissenburger, Jacques ^b   Hondeghem, Luc ^c   Ertel, Eric A ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b SORBONNE UNIVERSITÉ   (France)

^c Hondeghem Pharmaceutical Consulting   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; MIBEFRADIL; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; GUINEA PIG; HEART REPOLARIZATION; HUMAN; MONKEY; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; RABBIT; SQUIRREL MONKEY;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; GUINEA PIGS; HEART; HEART ATRIA; HUMANS; MALE; MIBEFRADIL; RABBITS; SAIMIRI; SOTALOL; TELEMETRY; TIME FACTORS; VERAPAMIL;

EID: 0342614952     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adamantidis M, Kerram P, Caron J and Dupuis B (1993) Droperidol exerts dual effects on repolarization and induces early afterdepolarizations and triggered activity in rabbit Purkinje fibers. J Pharmacol Exp Ther 266:884-893.
2. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, Di Diego JM, Gintant GA and Liu DW (1991) Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. Circ Res 69:1427-1449.
3. Anyukhovsky EP, Sosunov EA and Rosen MR (1996) Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium. In vitro and in vivo correlations. Circulation 94:1981-1988.
4. Avdonin V, Shibata EF and Hoshi T (1997) Dihydropyridine action on voltage-dependent potassium channels expressed in Xenopus oocytes. J Gen Physiol 109: 169-180.
5. Bénardeau A and Ertel EA (1998) Selective block of myocardial T-type calcium channels by mibefradil: A comparison with the 1,4-dihydropyridine amlodipine, in Low-Voltage-Activated T-Type Ca Channels (Tsien RW, Clozel J-P and Nargeot J eds) pp 386-394, Adis International, Chester, UK.
6. 2+ exchange to action potential of human atrial myocytes. Am J Physiol 40:H1151-H1161.
7. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H and Tomaselli GF (1997) Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy, Circulation 96:1557-1565.
8. Casas A, Graul A and Castañer J (1997) Mibefradil hydrochloride. Drugs Future 22:1091-1102.
9. + channels involved in long QT syndromes, are targets for calcium channel blockers. Mol Pharmacol 54:695-703.
10. Coraboeuf E and Nargeot J (1993) Electrophysiology of human cardiac cells. Cardiovasc Res 27:1713-1725.
11. Epstein M (1997) Calcium channel blockers and hypertension: Evolving perspective1996. Cardiovasc Drugs Ther 10 (Suppl 3):883-891.
12. Ertel SI and Clozel J-P (1997) Mibefradil (Ro 40-5967): The first selective T-type Ca2+ channel blocker. Exp Opin Invest Drugs 6:569-582.
13. Firek L and Giles WR (1995) Outward currents underlying repolarization in human atrial myocytes. Cardiovasc Res 30:31-38.
14. Giles TD (1997) Mibefradil (posicor). Comp Ther 23:761-763.
15. 2+ antagonists and agonists in rabbit cardiac myocytes. Am J Physiol 260:H1737-H1742.
16. Hiromasa S, Coto H, Li ZY, Maldonado C and Kupersmith J (1988) Dextrorotatory isomer of sotalol: Electrophysiologic effects and interaction with verapamil. Am Heart J 116:1552-1557.
17. Hondeghem LM (1994) Computer aided development of antiarrhythmic agents with class IIIa properties. J Cardiovasc Electrophysiol 5:711-721.
18. Kobrin I, Charlon V, Lindberg E, Neumann N and Pordy R (1997) Mibefradil: A new T-channel selective calcium antagonist. Drugs Today 33:523-542.
19. Lefevre IA, Coulombe A and Coraboeuf E (1991) The calcium antagonist D600 inhibits calcium-independent transient outward current in isolated rat ventricular myocytes. J Physiol (Lond) 432:65-80.
20. Le Grand B, Hatem S, Deroubaix E, Couetil J and Coraboeuf E (1991) Calcium current depression in isolated human atrial myocytes after cessation of chronic treatment with calcium antagonists. Circ Res 69:292-300.
21. Le Grand BL, Hatem S, Deroubaix E, Couetil JP and Coraboeuf E (1994) Depressed transient outward and calcium currents in dilated human atria. Cardiovasc Res 28:548-556.
22. Li GR and Nattel S (1997) Properties of human atrial ICa at physiological temperatures and relevance to action potential. Am J Physiol 272:H227-H235.
23. ++ inward currents by Ro 40-5967 and verapamil: Relation to negative inotropy. Eur J Pharmacol 196:205-207.
24. Matyus P, Varro A, Papp JG, Wamhoff H, Varga I and Virag L (1997) Antiarrhythmic agents: Current status and perspectives. Med Res Rev 17:427-451.
25. 2+ channels by Ro 40-5967. Circ Res 75:144-148.
26. Nilius B, Prenen J, Kamouchi M, Viana F, Voets T and Droogmans G (1997) Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)-and volume-activated C1-channels in macrovascular endothelial cells. Br J Pharmacol 121:547-555.
27. Noguchi K, Tanaka H and Shigenobu K (1997) Myocardial action potential prolongation by calcium channel activation under calcium free-EGTA conditions in guinea-pigs: Developmental and regional variations. Res Commun Mol Pathol Pharmacol 97:325-334.
28. Osaka T, Kodama I, Toyama J and Yamada K (1988) Effects of bepridil on ventricular depolarization and repolarization of rabbit isolated hearts with particular reference to its possible proarrhythmic properties. Br J Pharmacol 93:775-780.
29. 2+ channel antagonist Ro 405967. J Physiol (Lond) 485:P49-P50.
30. Shibata EF, Drury T, Refsum H, Aldrete V and Giles W (1989) Contributions of a transient outward current to repolarization in human atrium. Am J Physiol 257:H1773-H1781.
31. Somberg J, Torres V, Flowers D, Miura D, Butler B and Gottlieb S (1985) Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J 109:19-27.
32. Varro A, Lathrop DA, Hester SB, Nanasi PP and Papp JG (1993) Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Basic Res Cardiol 88:93-102.
33. Vos MA, Verduyn SC, Gorgels AP, Lipcsei GC and Wellens HJ (1995) Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 91: 864-872.
34. Wang Z, Fermini B and Nattel S (1993a) Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 73:276-285.
35. + current similar to Kv1.5 cloned channel currents. Circ Res 73:1061-1076.
36. Wegener JW and Nawrath H (1996) Action of tertiary phenylalkylamines on cardiac transient outward current from outside the cell membrane. Naunyn-Schmiedeberg's Arch Pharmacol 354:746-754.
37. Weissenburger J, Davy JM, Chezalviel F, Ertzbischoff O, Poirier JM, Engel F, Lainee P, Penin E, Motte G and Cheymol G (1991) Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: Comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. J Pharmacol Exp Ther 259:871-883.
38. Weissenburger J, Noyer M, Cheymol G and Jaillon P (1999) Electrophysiological effects of cetirizine, astemizole and d-sotalol in a canine model of long QT syndrome. Clin Exp Allergy 29 (Suppl 3):190-196.
39. Wiltshire HR, Sutton BM, Heeps G, Betty AM, Angus DW, Madigan MJ and Sharp SR (1997) Metabolism of the calcium antagonist, mibefradil (POSICOR, Ro 40-5967). Part II. Metabolism in hepatic microsomes from rat, marmoset, cynomolgus monkey, rabbit and man. Xenobiotica 27:539-556.
40. Winslow R, Kimball A, Varghese A and Noble D (1993) Simulating cardiac sinus and atrial network dynamics on the Connection Machine. Physica D: Nonlinear Phenomena 84:281-298.